Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glyceraldehyde-3-phosphate is a three-carbon phosphorylated sugar (aldotriose) that serves as an important metabolic intermediate in glycolysis, gluconeogenesis, the Calvin cycle in photosynthesis, tryptophan biosynthesis, and thiamine metabolism. It is formed from the cleavage of fructose 1,6-bisphosphate and can interconvert with dihydroxyacetone phosphate. It is not itself a protein, enzyme, receptor, or other classic drug target, but rather a substrate or product in central metabolic pathways in all domains of life. The correct drug target associated with this molecule is glyceraldehyde-3-phosphate dehydrogenase (GAPDH), an enzyme that acts on G3P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glyceraldehyde-3-phosphate (G3P (also GA3P, GADP, GAP, TP, GALP, PGAL)).